Literature DB >> 9205126

Genomic organization and primary characterization of miap-3: the murine homologue of human X-linked IAP.

R Farahani1, W G Fong, R G Korneluk, A E MacKenzie.   

Abstract

IAPs (inhibitor of apoptosis proteins) are a recently identified family of proteins that function in the cell death pathway to inhibit programmed cell death. We have earlier reported cloning of four human IAPs: NAIP, hiap-1, hiap-2, and xiap. To facilitate studies of these genes, we have undertaken the cloning of their murine homologues. We report here the cloning, mapping, and preliminary characterization (including cellular and tissue distribution profile) of the murine homologue of the human X-linked IAP (xiap). The mouse gene called miap-3 (for murine IAP-3; GenBank Accession No. nuc 1 U88990) has a coding region of 1.5 kb that encodes a protein of 55 kDa and has 87 and 94% homology with its human homologue at DNA and amino acid levels, respectively. Northern blot analysis reveals an 8-kb miap-3 transcript in all tissues examined to date. miap-3 is composed of six exons and five introns spanning approximately 20 kb. miap-3 has been assigned to the A3-A5 region of mouse chromosome X by FISH analysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9205126     DOI: 10.1006/geno.1997.4742

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Spurious splicing within the XIAP 5' UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporter system.

Authors:  Martin Holcik; Tyson Graber; Stephen M Lewis; Charles A Lefebvre; Eric Lacasse; Stephen Baird
Journal:  RNA       Date:  2005-09-21       Impact factor: 4.942

2.  Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation.

Authors:  C M Troy; S A Rabacchi; J B Hohl; J M Angelastro; L A Greene; M L Shelanski
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Characterization of XIAP-deficient mice.

Authors:  H Harlin; S B Reffey; C S Duckett; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells.

Authors:  H Lin; C Chen; B D Chen
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

5.  Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation.

Authors:  M Holcik; R G Korneluk
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Control of Bcl-2 expression by reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; Bruce Aronow; Sara Wojciechowski; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Apoptotic sensitivity of murine IAP-deficient cells.

Authors:  Julie M Rumble; Mathieu J M Bertrand; Rebecca A Csomos; Casey W Wright; Lori Albert; Tak W Mak; Philip A Barker; Colin S Duckett
Journal:  Biochem J       Date:  2008-10-01       Impact factor: 3.857

Review 8.  Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.

Authors:  A M Verhagen; E J Coulson; D L Vaux
Journal:  Genome Biol       Date:  2001-07-05       Impact factor: 13.583

9.  Cloning and characterization of the rat homologues of the Inhibitor of Apoptosis protein 1, 2, and 3 genes.

Authors:  Martin Holcik; Charles A Lefebvre; Keiko Hicks; Robert G Korneluk
Journal:  BMC Genomics       Date:  2002-02-11       Impact factor: 3.969

10.  Molecular characterization of an inhibitor of apoptosis protein (IAPs) in freshwater pearl mussel, Hyriopsis schlegelii.

Authors:  Di Wu; Chengyuan Wang; Wanchang Zhang; Kou Peng; Junqing Sheng; Junhua Wang; Archana Jain; Yijiang Hong
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.